Baystate Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$179K Buy
322
+14
+5% +$6.57K 0.01% 211
2023
Q3
$135K Hold
308
0.01% 227
2023
Q2
$155K Buy
308
+58
+23% +$27.8K 0.01% 210
2023
Q1
$125K Buy
250
+9
+4% +$4.31K 0.01% 224
2022
Q4
$98K Buy
241
+11
+5% +$4.27K 0.01% 254
2022
Q3
$75K Buy
230
+14
+6% +$5.14K 0.01% 263
2022
Q2
$76K Sell
216
-2
-0.9% -$816 0.01% 269
2022
Q1
$119K Buy
218
+67
+44% +$35.2K 0.01% 224
2021
Q4
$99K Buy
151
+15
+11% +$9.42K 0.01% 244
2021
Q3
$85K Hold
136
0.01% 237
2021
Q2
$86K Hold
136
0.01% 223
2021
Q1
$67K Buy
136
+17
+14% +$8.52K 0.01% 232
2020
Q4
$59K Buy
119
+2
+2% +$895 0.01% 235
2020
Q3
$46K Sell
117
-72
-38% -$26.6K 0.01% 229
2020
Q2
$62K Buy
189
+75
+66% +$21.7K 0.01% 206
2020
Q1
$28K Sell
114
-180
-61% -$47K ﹤0.01% 246
2019
Q4
$77K Hold
294
0.01% 189
2019
Q3
$80K Hold
294
0.01% 171
2019
Q2
$82K Hold
294
0.01% 170
2019
Q1
$66K Hold
294
0.01% 183
2018
Q4
$59K Hold
294
0.01% 182
2018
Q3
$64K Buy
294
+42
+17% +$10.2K 0.01% 170
2018
Q2
$59K Hold
252
0.01% 172
2018
Q1
$50K Hold
252
0.01% 187
2017
Q4
$46K Hold
252
0.01% 205
2017
Q3
$40K Hold
252
0.01% 207
2017
Q2
$42K Buy
252
+180
+250% +$29.2K 0.01% 196
2017
Q1
$11K Hold
72
﹤0.01% 329
2016
Q4
$8K Buy
+72
New +$8.22K ﹤0.01% 323
2013
Q3
Sell
-72
Closed -$3K 111
2013
Q2
$3K Buy
+72
New +$3.15K ﹤0.01% 251

Other funds holding IDXX

Baystate Wealth Management's IDXX Position: Q4 2023 in Review

Baystate Wealth Management increased its Idexx Laboratories (IDXX) stake by 4.5% in Q4 2023, buying an estimated $6.57K and bringing the position to 322 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #211.

Baystate Wealth Management first reported a position in IDXX in Q2 2013 and has held it in 30 quarters since. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Baystate Wealth Management held 322 shares of Idexx Laboratories worth $179K as of Q4 2023.
  • Baystate Wealth Management bought 14 Idexx Laboratories shares in Q4 2023, an estimated $6.57K.
  • Idexx Laboratories made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #211 holding.
  • Baystate Wealth Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 30 quarters since.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.